Investigational Site Number 380001

Milan 20141

0 studies enrolling now · 9 studies all time

What they study most

Dementia Alzheimer's Type, Diffuse Large B-cell Lymphoma, Hematopoietic Neoplasm, Malignant Solid Tumors, Multiple Sclerosis, Systemic Sclerosis, Type 2 Diabetes, Type 2 Diabetes Mellitus, Uveitis

Studies at this site

• Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib — Stopped early
• Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications — Completed
• SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients — Completed
• Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis — Completed
• Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM — Completed
• Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients — Completed
• Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors — Completed
• Proof of Biological Activity of SAR100842 in Systemic Sclerosis — Completed
• Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil — Completed